- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.49 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ASC: ASCORBIC ACID(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.2: 5 residues within 4Å:- Chain A: E.334, D.338, S.381, S.383
- Ligands: ASC.1
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.381
NA.3: 6 residues within 4Å:- Chain A: G.58, V.62, S.110, A.111, F.112
- Ligands: ASC.1
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.58
NA.12: 5 residues within 4Å:- Chain B: E.334, D.338, S.381, S.383
- Ligands: ASC.11
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.338
NA.13: 6 residues within 4Å:- Chain B: G.58, V.62, S.110, A.111, F.112
- Ligands: ASC.11
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.110
- 4 x AV0: Lauryl Maltose Neopentyl Glycol(Non-covalent)
AV0.4: 10 residues within 4Å:- Chain A: Y.284
- Chain B: Y.474, N.478, G.480, A.481, N.483, T.484, G.485, L.493
- Ligands: LBN.5
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:L.493
- Hydrogen bonds: B:Y.474, B:N.483
AV0.6: 13 residues within 4Å:- Chain A: L.219, L.223, Y.227, L.228, N.230, L.231, F.252
- Chain B: L.507, I.510, L.511, T.514, P.516
- Ligands: LBN.5
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:L.507, B:L.511, B:T.514, A:L.219, A:L.223, A:Y.227, A:Y.227
AV0.14: 10 residues within 4Å:- Chain A: Y.474, N.478, G.480, A.481, N.483, T.484, G.485, L.493
- Chain B: Y.284
- Ligands: LBN.15
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.493
- Hydrogen bonds: A:Y.474, A:N.483
AV0.16: 13 residues within 4Å:- Chain A: L.507, I.510, L.511, T.514, P.516
- Chain B: L.219, L.223, Y.227, L.228, N.230, L.231, F.252
- Ligands: LBN.15
7 PLIP interactions:4 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:L.219, B:L.223, B:Y.227, B:Y.227, A:L.507, A:L.511, A:T.514
- 2 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
LBN.5: 15 residues within 4Å:- Chain A: H.210, W.211, G.212, A.215, I.218, L.219, Y.284
- Chain B: F.463, F.467, L.471, L.475, A.481, L.507
- Ligands: AV0.4, AV0.6
13 PLIP interactions:5 interactions with chain B, 8 interactions with chain A- Hydrophobic interactions: B:F.463, B:F.467, B:L.471, B:L.475, B:L.507, A:W.211, A:W.211, A:W.211, A:W.211, A:A.215, A:I.218, A:L.219
- Salt bridges: A:H.210
LBN.15: 15 residues within 4Å:- Chain A: F.463, F.467, L.471, L.475, A.481, L.507
- Chain B: H.210, W.211, G.212, A.215, I.218, L.219, Y.284
- Ligands: AV0.14, AV0.16
13 PLIP interactions:5 interactions with chain A, 8 interactions with chain B- Hydrophobic interactions: A:F.463, A:F.467, A:L.471, A:L.475, A:L.507, B:W.211, B:W.211, B:W.211, B:W.211, B:A.215, B:I.218, B:L.219
- Salt bridges: B:H.210
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.7: 8 residues within 4Å:- Chain A: M.262, T.263, W.265, L.266, Y.269, T.290, D.295, L.419
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:M.262, A:W.265, A:W.265, A:W.265, A:L.266, A:Y.269, A:Y.269, A:Y.269, A:Y.269, A:T.290, A:L.419
- Hydrogen bonds: A:D.295
CLR.8: 11 residues within 4Å:- Chain A: I.183, T.187, T.191, L.322, F.325, L.329, L.496, F.502, G.505, C.506, F.509
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:I.183, A:I.183, A:T.187, A:T.191, A:L.322, A:F.325, A:F.325, A:L.329, A:L.329, A:L.496, A:F.502, A:F.502, A:F.509, A:F.509
- Hydrogen bonds: A:T.191
CLR.17: 8 residues within 4Å:- Chain B: M.262, T.263, W.265, L.266, Y.269, T.290, D.295, L.419
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:M.262, B:W.265, B:W.265, B:W.265, B:L.266, B:Y.269, B:Y.269, B:Y.269, B:Y.269, B:T.290, B:L.419
- Hydrogen bonds: B:D.295
CLR.18: 11 residues within 4Å:- Chain B: I.183, T.187, T.191, L.322, F.325, L.329, L.496, F.502, G.505, C.506, F.509
15 PLIP interactions:15 interactions with chain B- Hydrophobic interactions: B:I.183, B:I.183, B:T.187, B:T.191, B:L.322, B:F.325, B:F.325, B:L.329, B:L.329, B:L.496, B:F.502, B:F.502, B:F.509, B:F.509
- Hydrogen bonds: B:T.191
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 2 x PLM: PALMITIC ACID(Covalent)
PLM.10: 10 residues within 4Å:- Chain A: I.96, V.100, F.361, T.362, I.365, F.546, V.553, L.559, I.564, C.565
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.96, A:V.100, A:F.361, A:I.365, A:L.559, A:I.564
PLM.20: 10 residues within 4Å:- Chain B: I.96, V.100, F.361, T.362, I.365, F.546, V.553, L.559, I.564, C.565
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:I.96, B:V.100, B:F.361, B:I.365, B:L.559, B:I.564
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kobayashi, T.A. et al., Dimeric transport mechanism of human vitamin C transporter SVCT1. Nat Commun (2024)
- Release Date
- 2024-05-22
- Peptides
- Solute carrier family 23 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.49 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ASC: ASCORBIC ACID(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 4 x AV0: Lauryl Maltose Neopentyl Glycol(Non-covalent)
- 2 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 2 x PLM: PALMITIC ACID(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kobayashi, T.A. et al., Dimeric transport mechanism of human vitamin C transporter SVCT1. Nat Commun (2024)
- Release Date
- 2024-05-22
- Peptides
- Solute carrier family 23 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.